Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Canadian Solar
CSIQ
$1.02B
| $3.76M | ﹤0.01% |
131,355
-399,879
| -75% | -$13.7M |
|
3177
PUT
DaVita
DVA
$15.4B
| $3.75M | ﹤0.01% |
47,200
-531,400
| -92% | -$43.6M |
|
|
MTGE
3178
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $3.75M | ﹤0.01% |
234,421
+62,778
| +37% | +$1.1M |
|
3179
Post Holdings
POST
$4.14B
| $3.75M | ﹤0.01% |
106,184
-4,339
| -4% | -$134K |
|
|
RENX
3180
DELISTED
RELX N.V.
RENX
| $3.75M | ﹤0.01% |
246,034
+13,392
| +6% | +$214K |
|
3181
PUT
GSK
GSK
$104B
| $3.74M | ﹤0.01% |
71,840
+5,120
| +8% | +$288K |
|
3182
Colliers International
CIGI
$5.04B
| $3.74M | ﹤0.01% |
97,084
+62,603
| +182% | +$2.42M |
|
3183
iShares MSCI Singapore ETF
EWS
$1.04B
| $3.73M | ﹤0.01% |
148,258
+58,723
| +66% | +$1.55M |
|
3184
GATX Corp
GATX
$6.35B
| $3.71M | ﹤0.01% |
69,815
-17,663
| -20% | -$1M |
|
|
MDP
3185
DELISTED
Meredith Corporation
MDP
| $3.7M | ﹤0.01% |
71,004
-79,614
| -53% | -$4.22M |
|
|
INSY
3186
PUT
DELISTED
Insys Therapeutics, Inc.
INSY
| $3.7M | ﹤0.01% |
103,000
+67,800
| +193% | +$2.11M |
|
|
DFS
3187
CALL
DELISTED
Discover Financial Services
DFS
| $3.69M | ﹤0.01% |
64,100
-39,900
| -38% | -$2.34M |
|
3188
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.79B
| $3.69M | ﹤0.01% |
87,679
+74,151
| +548% | +$3.34M |
|
3189
PUT
Canadian Imperial Bank of Commerce
CM
$108B
| $3.69M | ﹤0.01% |
100,000
| – | – |
|
3190
Cogent Communications
CCOI
$676M
| $3.68M | ﹤0.01% |
108,865
-27,809
| -20% | -$932K |
|
3191
CALL
Groupon
GRPN
$1.05B
| $3.68M | ﹤0.01% |
36,580
-6,820
| -16% | -$880K |
|
3192
CALL
New Oriental
EDU
$9.37B
| $3.68M | ﹤0.01% |
+150,000
| New | +$3.72M |
|
3193
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.68B
| $3.68M | ﹤0.01% |
+58,345
| New | +$3.89M |
|
|
WMGI
3194
CALL
DELISTED
Wright Medical Group Inc
WMGI
| $3.68M | ﹤0.01% |
140,000
+90,000
| +180% | +$2.38M |
|
3195
KB Financial Group
KB
$41.4B
| $3.67M | ﹤0.01% |
111,759
-10,326
| -8% | -$372K |
|
3196
PUT
Hershey
HSY
$35.2B
| $3.67M | ﹤0.01% |
41,300
-10,400
| -20% | -$981K |
|
3197
United States Natural Gas Fund
UNG
$456M
| $3.67M | ﹤0.01% |
16,905
-16,227
| -49% | -$3.5M |
|
|
STJ
3198
PUT
DELISTED
St Jude Medical
STJ
| $3.67M | ﹤0.01% |
50,200
-99,700
| -67% | -$7.2M |
|
3199
CALL
Direxion Daily Small Cap Bear 3x ETF
TZA
$250M
| $3.67M | ﹤0.01% |
237
+59
| +33% | +$929K |
|
3200
UFP Industries
UFPI
$4.9B
| $3.66M | ﹤0.01% |
210,999
-13,506
| -6% | -$247K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.